Evidence map›Paper›PMID 42899409›Full record

ArticleBioinformatics (Oxford, England)2026

Integration of polygenic risk with single cell methylation data using met-scDRS.

Xinzhe Li, Zhuozheng Shi, Kangcheng Hou, Katherine W Eyring, Cuining Liu, Matthew G Heffel, Chongyuan Luo, Daniel H Geschwind, Bogdan Pasaniuc

Abstract read
PubMed Publisher
In one paragraph

Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Xinzhe LiGenomics and Computational Biology Program, University of Pennsylvania, Philadelphia, PA 19104, United States.ORCID 0009-0004-1254-9778
Zhuozheng ShiGenomics and Computational Biology Program, University of Pennsylvania, Philadelphia, PA 19104, United States.
Kangcheng HouDepartment of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA 02115, United States.
Katherine W EyringDepartment of Neurology, David Geffen School of Medicine, Neurogenetics Program, University of California, Los Angeles, Los Angeles, CA 90095, United States.
Cuining LiuBioinformatics Interdepartmental Program, University of California, Los Angeles, CA 90024, United States.ORCID 0000-0003-1079-0045
Matthew G HeffelDepartment of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, United States.
Chongyuan LuoDepartment of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, United States.ORCID 0000-0002-8541-0695
Daniel H GeschwindDepartment of Neurology, David Geffen School of Medicine, Neurogenetics Program, University of California, Los Angeles, Los Angeles, CA 90095, United States.ORCID 0000-0003-2896-3450
Bogdan PasaniucDepartment of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, United States.

Funding

Joint genomic and statistical analyses of schizophrenia and bipolar to decipher genetic susceptibilityR01MH115676 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Roel A Ophoff, Bogdan Pasaniuc · 2018 to 2026
$5.9M
PRS Center for Admixed Populations (CAPE)U01HG011715 · NHGRI · UNIVERSITY OF PENNSYLVANIA · PI Eimear Elizabeth Kenny, Leslie A Lange · 2021 to 2026
$5.2M
Integrative approaches for mapping the genetic risk of complex traitsR01HG009120 · NHGRI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI PASANIUC, BOGDAN · 2017 to 2021
$2.3M
NIH HHS R01HG009120NIH HHS R01MH115676NIH HHS U01HG011715
6 · The paper itself

Abstract

motivationAlthough large scale genome-wide association studies (GWAS) have identified many risk variants for psychiatric traits their functional implication remain largely unknown. One potential mechanism for their risk is through cellular context-dependent epigenetics such as methylation. Previous methodologies have focused on integrating GWAS with single cell transcriptomics, which allowed identification of within-cell-type heterogeneity in disease risk association. We extended this framework to provide a method called met-scDRS that integrates GWAS with single cell epigenomics and investigates how psychiatric disease risk can manifest through methylomics at single cell resolution.

resultsWe propose an approach that integrates single cell methylomes with disease associated genes identified from GWAS at single-cell resolution. We found our method to be well calibrated and powered in different scenarios. We then analysed a publicly available single cell methylome dataset of the human brain for 75 different traits and generated disease relevance scores for each cell for each trait. We find high brain specificity with major cell type enrichments congruent with known findings. We identify within-cell-type heterogeneity for psychiatric disease risk along the brain spatial axis as well as subpopulations that are differentially associated with diseases. Finally, we showed that genes with high correlation between methylation levels and disease relevance scores to be highly enriched in specific functional pathways such as synaptic formation and transmission. AVAILABILITY: met-scDRS is freely available in GitHub as a python package under MIT license: https://github.com/bogdanlab/met-scDRS. Source code is also available from Zenodo with DOI: 10.5281/zenodo.21841506. All dataset used in this work are publicly available.

Indexed as

DNA MethylationEpigenomicsGenome-Wide Association StudyMental DisordersMultifactorial InheritanceSingle-Cell AnalysisBrainEpigenesis, GeneticGenetic Predisposition to DiseaseGenetic Risk ScoreHumans

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.